Johnson & Johnson (JNJ) – Globe Newswire
-
Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
-
Press Release Biocartis Group NV: Disclosure of transparency notification
-
Galapagos appoints Thad Huston as Chief Financial Officer and Chief Operating Officer
-
Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®
-
Purpose Investments Files Preliminary Prospectus for the First Yield-Focused Single-Stock ETFs
-
Tactile Medical Announces New Appointments to Board of Directors
-
Helius Medical Technologies, Inc. Appoints Antonella Favit-Van Pelt, M.D., Ph.D. as Chief Medical Officer
-
Nextech AR’s Virtual Event Platform Selected by Canadian Surgery Forum for Its 2021 Virtual Trade Show
-
Biopharma Leaders Unite to Stand with Science
-
Biopharma Leaders Unite to Stand with Science
-
Aleafia Health Approved by Janssen Pharmaceuticals to Administer Antidepressant SPRAVATO®
-
Yield Growth Corp Provides Mid-Year 2019 Corporate Update
Back to JNJ Stock Lookup
